Rights issue in Coala-Life Group AB — SEK 150 million

Carnegie acted as sole global co-ordinator in the fully guaranteed rights issue of SEK 150 million. Coala Life is a medical device company founded in Sweden focusing on cloud-based cardiac and pulmonary diagnostics. The Company has developed and launched the Coala Heart Monitor – a multi-award winning, FDA-cleared and CE-approved product platform enabling long-term remote monitoring, analysis and algorithm-based diagnostics of heart and lungs in real-time.
April 2022.